Form 483

Pharmaceutics International, Inc. Form 483, 2011-05-25

FDA issued a Form 483 to Pharmaceutics International, Inc. on 2011-05-25 with 6 public-safe observations.

483· Form 483 issued6 observations

Pharmaceutics International, Inc. · Hunt Valley, United States · Issued May 25, 2011

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 May 2011
21 CFR 211.46(c)

Exhaust systems inadequate to control air contamination

Cited by Brooke K Higgins

25 May 2011
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Brooke K Higgins

25 May 2011
21 CFR 211.122(a)

Written procedures describing in detail

Cited by Brooke K Higgins

25 May 2011
21 CFR 211.125(a)

Strict control not exercised over labeling issued

Cited by Brooke K Higgins

25 May 2011
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Brooke K Higgins

Inspected site

PIPharmaceutics International, Inc.Hunt Valley, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.122(a)Cited across public-safe Form 483 observations1x
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(12)Cited across public-safe Form 483 observations1x
21 CFR 211.46(c)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere